Drug intelligence / Profile preview

Testomix

Development stage
Unknown
Lead developer
Endava
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Testomix is an injectable androgenic steroid blend developed by DEK Pharma, typically formulated at a high concentration of 400 mg/ml. It consists of a combination of multiple testosterone esters, including testosterone propionate, testosterone phenylpropionate, testosterone isocaproate, testosterone decanoate, and testosterone cypionate. By combining esters with varying absorption rates and half-lives, Testomix provides both immediate and sustained elevations in serum testosterone levels, allowing for less frequent administration compared to single-ester formulations. The drug acts as an agonist at the androgen receptor, promoting protein synthesis, muscle growth, and the maintenance of male secondary sexual characteristics. It is primarily indicated for the treatment of male hypogonadism and testosterone deficiency.

Brand names
Testomix
Other names
Testomix 400Testomix400Testomix-400Testomix 400 mg/ml
02

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on Testomix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Testomix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call